These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28217982)

  • 1. Theranostic Nanoparticles Loaded with Imaging Probes and Rubrocurcumin for Combined Cancer Therapy by Folate Receptor Targeting.
    Alberti D; Protti N; Franck M; Stefania R; Bortolussi S; Altieri S; Deagostino A; Aime S; Geninatti Crich S
    ChemMedChem; 2017 Apr; 12(7):502-509. PubMed ID: 28217982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin loaded β-cyclodextrin-magnetic graphene oxide nanoparticles decorated with folic acid receptors as a new theranostic agent to improve prostate cancer treatment.
    Einafshar E; Javid H; Amiri H; Akbari-Zadeh H; Hashemy SI
    Carbohydr Polym; 2024 Sep; 340():122328. PubMed ID: 38857995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
    Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
    Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
    Saxena V; Naguib Y; Hussain MD
    Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia.
    Balasubramanian S; Girija AR; Nagaoka Y; Iwai S; Suzuki M; Kizhikkilot V; Yoshida Y; Maekawa T; Nair SD
    Int J Nanomedicine; 2014; 9():437-59. PubMed ID: 24531392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
    Patel NR; Piroyan A; Ganta S; Morse AB; Candiloro KM; Solon AL; Nack AH; Galati CA; Bora C; Maglaty MA; O'Brien SW; Litwin S; Davis B; Connolly DC; Coleman TP
    Cancer Biol Ther; 2018 Jul; 19(7):554-564. PubMed ID: 29737910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.
    Ganta S; Singh A; Rawal Y; Cacaccio J; Patel NR; Kulkarni P; Ferris CF; Amiji MM; Coleman TP
    Drug Deliv; 2016; 23(3):968-80. PubMed ID: 24901206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
    Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
    Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.
    Fasehee H; Dinarvand R; Ghavamzadeh A; Esfandyari-Manesh M; Moradian H; Faghihi S; Ghaffari SH
    J Nanobiotechnology; 2016 Apr; 14():32. PubMed ID: 27102110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
    Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
    Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate decorated dual drug loaded nanoparticle: role of curcumin in enhancing therapeutic potential of nutlin-3a by reversing multidrug resistance.
    Das M; Sahoo SK
    PLoS One; 2012; 7(3):e32920. PubMed ID: 22470431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
    Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
    J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of PLGA based nanoparticles for imaging guided applications.
    Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S
    Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line.
    Roointan A; Sharifi-Rad M; Badrzadeh F; Sharifi-Rad J
    Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(9):51-6. PubMed ID: 27585262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.